TesoRx Pharma said Tuesday that it has secured $10 million in Series B-1 funding. The investors were not named. Based in Menlo Park, Calif., TesoRx is focused on developing and commercializing products in specialty and niche markets.

from PE Hub Blog http://ift.tt/1v6LA33
via IFTTT

Advertisements